Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma

NCT00590941 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Diffuse Large Cell

Interventions

PROCEDURE: Blood draw

Sponsor

Washington University School of Medicine